Literature DB >> 30175653

Patient care for postamputation pain and the complexity of therapies: living experiences.

Marjorie Flahaut1, Nicolas L Laurent1, Murielle Michetti1, Nathalie Hirt-Burri1, Winnie Jensen2, Romulus Lontis2, Lee A Applegate1, Wassim Raffoul1.   

Abstract

AIM: Limb amputation traumatically alters body image. Sensations rapidly prevail that the limb is still present and 85% of patients portray phantom limb pain. Throughout the testimonies of amputated patients with intense phantom limb pain, we show the difficulty in treating this chronic pain with current pharmacological and nonpharmacological therapies. PATIENTS &
METHODS: We qualitatively analyzed the therapeutic choices of five amputees, the effectiveness of the treatments chosen and the impact on patients' quality-of-life. RESULTS &
CONCLUSION: In general, patients who are refractory to pharmacological treatments are in favor of trying alternative therapies. It is therefore crucial to design a combined and personalized therapeutic plan under the coordination of a multidisciplinary team for the wellbeing of the patient.

Entities:  

Keywords:  chronic pain; complementary and alternative medicine therapies; neuropathic pain; phantom limb pain; pharmacological therapies; postamputation pain; rehabilitation; therapy

Mesh:

Year:  2018        PMID: 30175653     DOI: 10.2217/pmt-2018-0033

Source DB:  PubMed          Journal:  Pain Manag        ISSN: 1758-1869


  2 in total

1.  Multicenter, Double-Blinded, Randomized, Active-Sham Controlled Clinical Study Design to Assess the Safety and Effectiveness of a Novel High Frequency Electric Nerve Block System in the Treatment of Post-Amputation Pain (The QUEST Study).

Authors:  Leonardo Kapural; Nemath Syed Shah; Zi-Ping Fang; Nagy Mekhail
Journal:  J Pain Res       Date:  2022-06-03       Impact factor: 2.832

2.  Icing the Pain-Ultrasound-Guided Cryoablation of Symptomatic Post-Amputation Stump Neuroma.

Authors:  C von Falck; M Orgel; F Wacker; H H Aschoff; C Krettek; K I Ringe
Journal:  Cardiovasc Intervent Radiol       Date:  2021-11-24       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.